Among laboratory parameters, patients with glioma WHO IV had significantly higher WBCs, neutrophils, and monocyte counts (p value < 0.05), and significantly lower lymphocyte counts and albumin levels compared to healthy controls (p value < 0.05). This evidence concerns the gene ALB and central nervous system cancer.